Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Several companies, including Oracle and Microsoft, are expected to sign pledges to work on the Trump administration ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

President Donald Trump on Wednesday made a fresh push to improve Americans’ access to their own medical records, tasking ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

The Trump administration is considering a shift in health care coverage, allowing Medicare and Medicaid to cover GLP-1 weight ...